CINITAPRIDE HYDROGEN TARTRATE
-
CINITAPRIDE HYDROGEN TARTRATE
structure -
-
CAS No:
66564-14-5
-
Formula:
C21H30N4O4
-
Chemical Name:
CINITAPRIDE HYDROGEN TARTRATE
-
Synonyms:
CINITAPRIDE HYDROGEN TARTRATE;CinitaprideTartrate;Cidine;LAS-17177;4-Amino-N-[1-(3-cyclohexen-1-ylmethyl)-4-piperidyl]-2-ethoxy-5-nitrobenzamide;4-Amino-N-[1-(3-cyclohexen-1-ylmethyl)-4-piperidinyl]-2-ethoxy-5-nitrobenzamide;BenzaMide,4-aMino-N-[1-(3-cyclohexen-1-ylMethyl)-4-piperidinyl]-2-ethoxy-5-nitro-;4-amino-N-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-2-ethoxy-5-nitrobenzamide
-
CAS No:
Description
White Solid
Solid
Cinitapride is an aromatic ether and a C-nitro compound.|Cinitapride is a gastroprokinetic agent and antiulcer benzamide with agonist activity at 5-HT1 and 5-HT4 receptors and antagonist activity at 5-HT2 receptors. It is marketed in Spain and Mexico.
Cinitapride is a substituted benzamide dopamine receptor antagonist effective in the treatment of gastroesophageal reflux and a variety of gastrointestinal motility disorders. It generates strong procholinergic activity in the gastrointestinal tract by elevating the serotonergic transmission in the mysenteric plexus.
ChEBI: Cinitapride is an aromatic ether and a C-nitro compound.
CINITAPRIDE HYDROGEN TARTRATE Basic Attributes
402.49
402.49
Yellow
A - Alimentary tract and metabolism
Characteristics
113
3.87
1.24
>197°C (dec.)
579.8±50.0 °C(Predicted)
304.5±30.1 °C
1.603
12.62±0.20(Predicted)
Refrigerator
Drug Information
It is indicated to treat gastrointestinal disorders associated with motility disturbances like gastroesophageal reflux disease (GERD), non-ulcer dyspepsia and delayed gastric emptying.
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
The absorption of cinitapride (12mg) following oral administration was rapid, with peak levels being achieved 2 h after dosing; absorption following intramuscular administration (4mg) was even more rapid, with peak levels (50% more that oral levels) being achieved 1 h after dosing.
3-5 h during the first 8 h and a residual half-life greater than 15 h thereafter.
Cinitapride is a substituted benzamide with 5-HT receptor antagonist and agonist activity.
4-Amino-N-(1-(3-cyclohexen-1-ylmethyl)-4-piperidyl)-2-ethoxy-5-nitrobenzamide
CINITAPRIDE HYDROGEN TARTRATE Use and Manufacturing
A novel prokinetic benzamide-stimulating gastrointestinal motility agent and antiucer agent. It acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors.
serotonin-norepinephrine reuptake inhibitor, antidepressant
Computed Properties
Molecular Weight:402.5
XLogP3:3.6
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:6
Exact Mass:402.22670545
Monoisotopic Mass:402.22670545
Topological Polar Surface Area:113
Heavy Atom Count:29
Complexity:586
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of CINITAPRIDE HYDROGEN TARTRATE
-
![India]()
IN
6 YRS
Business licensed Certified factoryManufactory Supplier of Rabeprazole,Omeprazole,Silodosin,Levocetririzine
Learn More Other Chemicals
-
Decyl 3,5,5-trimethylhexyl hydrogen phosphate
85006-33-3
-
hydrogen sulfate;propylaminoazanium
73941-19-2
-
propyl hydrogen sulfate
13425-84-8
-
[[(2R,3S,4S,5R)-3,4-dihydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Formula
66097-68-5
-
4-Methyl hydrogen aspartate Formula
1835-51-4
-
Cuprate(3-), [5-amino-4-(hydroxy-κO)-3-[2-[2-(hydroxy-κO)-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl-κN1]-2,7-naphthalenedisulfonato(5-)]-, hydrogen (1:3) Formula
68039-61-2
-
Titanate(2-), bis(didodecyl phosphito-κO′′)tetrakis(octyloxy)-, hydrogen (1:2), branched and linear Structure
68585-66-0
-
Titanate(2-), bis(didodecyl phosphito-κO′′)tetrakis(2-propanolato)-, hydrogen (1:2) Structure
64157-15-9
-
What is methyl hydrogen sulfate;2-[4-(2-methyl-3,3,3-triphenylpropyl)piperazin-1-yl]pyrimidine
36371-43-4
-
What is Cuprate(4-), [5-(acetylamino)-4-(hydroxy-κO)-3-[2-[1-(hydroxy-κO)-6-sulfo-8-[[2-(sulfooxy)ethyl]sulfonyl]-2-naphthalenyl]diazenyl-κN1]-2,7-naphthalenedisulfonato(6-)]-, hydrogen (1:4)
33773-63-6